Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis

Author(s):
Heijde, D. van der; Landewe, R.B.; Mease, P.J.; McInnes, I.B.; Conaghan, P.G.; Pricop, L.; Ligozio, G.; Richards, H.B.; Mpofu, S.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-08-31
Language
English
Is part of
Arthritis and Rheumatology (2016), Vol. 68, no. 8, p. 1914-1921
hdl
1887/112362
doi
10.1002/art.39685